-------如果这里没有任何信息，不是真没有，是我们懒！请复制书名上amazon搜索书籍信息。-------
Learn the Latest Best PracticesUsing both routine microscopic examination and immunohistochemistry, this online CME program outlines best practices for specimen handling and reporting, defined diagnostic criteria, improved recognition of less common diagnostic entities, and accurate interpretation of ancillary studies. Along with defining the role of newer adjunctive molecular tests, this breast pathology CME course will also help you to better:Classify proliferative breast, in situ, papillary, fibroepithelial, spindle cell, and vascular lesionsMake the distinction between invasive and in situ lesionsIdentify a variety of uncommon benign and malignant lesionsUnderstand guidelines for reporting prognostic and predictive factorsExpand Your SkillsAvailable online or via USB, Masters of Pathology Series – Breast Pathology provides a maximum of 17.25 AMA PRA Category 1 Credits ™ and access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice.DesignationOakstone Publishing designates this enduring material for a maximum of 17.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Date of Original Release: November 1, 2020Date Credits Expire: November 1, 2023Learning ObjectivesAt the conclusion of this CME activity, the participant will be able to:Evaluate diagnostic criteria and clinical significance of various common and uncommon benign, in situ and malignant lesions of the breast in both core needle biopsy specimens and surgical excision specimensDescribe differential diagnostic problems commonly encountered in breast pathology and develop strategies to resolve them in the practice environmentUtilize the latest information on the uses and limitations of immunohistochemistry in resolving diagnostic problems in breast pathologyUnderstand the updated guidelines for ER, PR and HER2 testing and reportingUnderstand the applications of molecular testing in breast cancerTopics : Intraductal Proliferative Lesions - Laura C. Collins, MDIntraductal Proliferative Lesions - Microscopy Session - Laura C. Collins, MDPapillary Lesions of the Breast: A Brief Practical Diagnostic Review - Marissa White, MDPapillary Lesions of the Breast - Microscopy Session - Marissa White, MDContemporary Considerations for Breast Core Needle Biopsies - Laura C. Collins, MDLobular Carcinoma In Situ - Edi Brogi, MD, PhDLobular Carcinoma In Situ - Microscopy Session - Edi Brogi, MD, PhDFibroepithelial Lesions - Edi Brogi, MD, PhDFibroepithelial Lesions - Microscopy Session - Edi Brogi, MD, PhDMucinous Lesions of the Breast - Beth Harrison, MDMucinous Lesions of the Breast - Microscopy Session - Beth Harrison, MDSpindle Cell Lesions of the Breast - Erinn Downs Kelly, MDSpindle Cell Lesions of the Breast - Microscopy Session - Erinn Downs Kelly, MDVascular Lesions of the Breast - Steven Billings, MDVascular Lesions of the Breast - Microscopy Session - Steven Billings, MDBreast Specimen Margin Evaluation - Stuart J. Schnitt, MDThe Challenge of Evaluating Post-Neoadjuvant Systemic Therapy Breast Specimens - Stuart J. Schnitt, MDUpdates in Hormone Receptor Testing - Kimberly Allison, MDUpdates in HER2 Testing - Kimberly Allison, MDThe Spectrum of Triple Negative Breast Cancers - Hannah Wen, MD, PhDThe Spectrum of Triple Negative Breast Cancers - Microscopy Session - Hannah Wen, MD, PhDPD-L1 Testing in Breast Cancer - Hannah Wen, MD, PhDPrognostic and Predictive Assays and Molecular Testing - Hannah Wen, MD, PhDApplications of Immunohistochemistry in Diagnostic Breast Pathology - Ashley Cimino-Mathews, MDSmall Glandular Proliferations and Mimics of Breast Carcinoma - Mara Rendi, MDSmall Glandular Proliferations - Microscopy Session - Mara Rendi, MDInflammatory and Reactive Conditions in the Breast - Timothy D'Alfonso, MDInflammatory and Reactive Conditions in the Breast - Microscopy Session - Timothy D'Alfonso, MD
